Status:
COMPLETED
Mometasone and Markers of Airway Inflammation
Lead Sponsor:
Creighton University
Collaborating Sponsors:
Schering-Plough
Conditions:
Asthma
Eligibility:
All Genders
19-50 years
Phase:
PHASE4
Brief Summary
A post-marketing study to look at the effects of Asmanex on markers of airway inflammation.
Detailed Description
Patients with asthma and not treated with anti-inflammatory medications were studied. This was a parallel, randomized, placebo-controlled study to investigate the effects of Asmanex on markers of airw...
Eligibility Criteria
Inclusion
- Asthma
- non-smoker
- FEV1 of at least 60% predicted
Exclusion
- Pregnancy or lactation
- Corticosteroid use in past 30 days
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00711165
Start Date
August 1 2005
End Date
August 1 2006
Last Update
July 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Creighton University Medical Center
Omaha, Nebraska, United States, 68131